Jivko Kamarashev

Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG

Dirk Schadendorf, Selma Ugurel, Beatrice Schuler‐Thurner et al. · Annals of Oncology · 2006 · 466 citations · Full text

Cancer Immunosurveillance, Medicine, Melanoma +9

Heterogeneous Tumor Subpopulations Cooperate to Drive Invasion

Anna Chapman, Laura Fernandez del Ama, Jennifer Ferguson et al. · Cell Reports · 2014 · 205 citations · Full text

Human Leukocyte Antigen G Up-Regulation in Lung Cancer Associates with High-Grade Histology, Human Leukocyte Antigen Class I Loss and Interleukin-10 Production

Mirjana Urosevic, Michael Kurrer, Jivko Kamarashev et al. · American Journal Of Pathology · 2001 · 201 citations · Full text

Oncology, Lung Cancer Associates, Medicine +8

PAX3 is expressed in human melanomas and contributes to tumor cell survival.

Florence A. Scholl, Jivko Kamarashev, Omar V. Murmann et al. · PubMed · 2001 · 122 citations

Tumor Biology, Medicine, Melanoma +15

Tyrosinase immunoreactivity in formalin‐fixed, paraffin‐embedded primary and metastatic melanoma: frequency and distribution

Günther F.L. Hofbauer, Jivko Kamarashev, Ralf Geertsen et al. · Journal of Cutaneous Pathology · 1998 · 115 citations